Cargando…
Genotypes of Pain and Analgesia in a Randomized Trial of Irritable Bowel Syndrome
BACKGROUND: Irritable bowel syndrome (IBS) is a highly prevalent chronic pain disorder with multiple underlying mechanisms and few treatments that have been demonstrated to be effective in placebo controlled trials. One potential reason may be the use of composite outcomes, such as the IBS Symptom S...
Autores principales: | Vollert, Jan, Wang, Ruisheng, Regis, Stephanie, Yetman, Hailey, Lembo, Anthony J., Kaptchuk, Ted J., Cheng, Vivian, Nee, Judy, Iturrino, Johanna, Loscalzo, Joseph, Hall, Kathryn T., Silvester, Jocelyn A. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8983929/ https://www.ncbi.nlm.nih.gov/pubmed/35401282 http://dx.doi.org/10.3389/fpsyt.2022.842030 |
Ejemplares similares
-
Genomic Effects Associated With Response to Placebo Treatment in a Randomized Trial of Irritable Bowel Syndrome
por: Wang, Rui-Sheng, et al.
Publicado: (2022) -
Open-label versus double-blind placebo treatment in irritable bowel syndrome: study protocol for a randomized controlled trial
por: Ballou, Sarah, et al.
Publicado: (2017) -
Pelvic Floor Symptom Related Distress in Chronic Constipation Correlates With a Diagnosis of Irritable Bowel Syndrome With Constipation and Constipation Severity but Not Pelvic Floor Dyssynergia
por: Singh, Prashant, et al.
Publicado: (2019) -
Randomized Clinical Trial: Crofelemer Treatment in Women With Diarrhea-Predominant Irritable Bowel Syndrome
por: Nee, Judy, et al.
Publicado: (2019) -
Patients’ experiences treated with open-label placebo versus double-blind placebo: a mixed methods qualitative study
por: Haas, Julia W., et al.
Publicado: (2022)